These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19663842)

  • 21. Annular groin eruptions: pityriasis rosea of vidal.
    Zawar V; Godse K
    Int J Dermatol; 2011 Feb; 50(2):195-7. PubMed ID: 21244385
    [No Abstract]   [Full Text] [Related]  

  • 22. Vesicular pityriasis rosea: response to erythromycin treatment.
    Miranda SB; Lupi O; Lucas E
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):622-5. PubMed ID: 15324412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistologic studies in pityriasis rosea. Evidence for cellular immune reaction in the lesional epidermis.
    Aiba S; Tagami H
    Arch Dermatol; 1985 Jun; 121(6):761-5. PubMed ID: 3890762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple recurrences of pityriasis rosea of Vidal: a novel presentation.
    Zawar V; Kumar R
    Clin Exp Dermatol; 2009 Jul; 34(5):e114-6. PubMed ID: 19508465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plantar herald patch in pityriasis rosea.
    Robati RM; Toossi P
    Clin Exp Dermatol; 2009 Mar; 34(2):269-70. PubMed ID: 19187313
    [No Abstract]   [Full Text] [Related]  

  • 26. One-year review of pityriasis rosea at the National Skin Centre, Singapore.
    Tay YK; Goh CL
    Ann Acad Med Singap; 1999 Nov; 28(6):829-31. PubMed ID: 10672397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation and clonality of lesional lymphocytes in pityriasis lichenoides chronica.
    Shieh S; Mikkola DL; Wood GS
    Arch Dermatol; 2001 Mar; 137(3):305-8. PubMed ID: 11255329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CX3C-chemokine fractalkine (CX3CL1) is detectable in serum of patients affected by active pityriasis rosea.
    Gangemi S; Cannavò SP; Guarneri F; Merendino RA; Sturniolo GC; Minciullo PL; Di Pasquale G; Valenzise M; Drago F; Rebora A
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1366-7. PubMed ID: 17062081
    [No Abstract]   [Full Text] [Related]  

  • 29. [Langerhans cells and their significance in inflammatory processes].
    Matarasso S; Zarone F; Grella V; Ramaglia L
    Minerva Stomatol; 1987 Jun; 36(6):433-8. PubMed ID: 3498116
    [No Abstract]   [Full Text] [Related]  

  • 30. Epidermal DR+T6- dendritic cells in inflammatory skin diseases.
    Baker BS; Lambert S; Powles AV; Valdimarsson H; Fry L
    Acta Derm Venereol; 1988; 68(3):209-17. PubMed ID: 2455413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vesicular palmoplantar pityriasis rosea.
    Singh V; Sharma M; Narang T; Madan M
    Skinmed; 2012; 10(2):116-8. PubMed ID: 22545332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent pityriasis rosea: A case report.
    Li A; Li P; Li Y; Li W
    Hum Vaccin Immunother; 2018 Apr; 14(4):1024-1026. PubMed ID: 29182459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological studies of pityriasis rosea (Gibert).
    Takaki Y; Koshiyama Y; Watanabe S
    J Dermatol; 1977 Feb; 4(1):37-40. PubMed ID: 16688920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases.
    Brazzelli V; Prestinari F; Roveda E; Barbagallo T; Bellani E; Vassallo C; Orlandi E; Passamonti F; Borroni G
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S240-3. PubMed ID: 16227099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pityriasis rosea with palmoplantar plaque lesions.
    Bukhari I
    Dermatol Online J; 2005 Mar; 11(1):27. PubMed ID: 15748568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolutionary changes of immunohistological characteristics of secondary lesions in pityriasis rosea.
    Sugiura H; Miyauchi H; Uehara M
    Arch Dermatol Res; 1988; 280(7):405-10. PubMed ID: 2462853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Unusual combination of clinical forms in a young man. Atypical pityriasis rosea].
    Meyersburg D; Bertsch HP; Neumann C
    Hautarzt; 2009 Mar; 60(3):246-9. PubMed ID: 18806969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pityriasis rosea.
    Truhan AP
    Am Fam Physician; 1984 May; 29(5):193-6. PubMed ID: 6731238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pityriasis rosea and herpesviruses: facts and controversies.
    Rebora A; Drago F; Broccolo F
    Clin Dermatol; 2010; 28(5):497-501. PubMed ID: 20797508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect on quality of life in patients with pityriasis rosea: is it associated with rash severity?
    Chuh AA; Chan HH
    Int J Dermatol; 2005 May; 44(5):372-7. PubMed ID: 15869534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.